SCHEMBL20909121

SCHEMBL20909121

COc1ccc([C@H](C)NCCCCl)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.55
KMT2A Q03164 4/20 0.52
ALDH1A1 P00352 4/20 0.52
HTT P42858 2/20 0.52
MITF O75030 1/20 0.52
LMNA P02545 1/20 0.52
MAPT P10636 1/20 0.52
OPRM1 P35372 2/20 0.47
MEN1 O00255 2/20 0.47
OPRD1 P41143 1/20 0.47
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
ACHE P22303 1/20 0.45
CASR P41180 3/20 0.45
SIGMAR1 Q99720 2/20 0.44
HTR1A P08908 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
SLC6A2 P23975 1/20 0.44
HRH2 P25021 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3265762 0.85 PKM (0.56) PKMKMT2AALDH1A1HTTMITF
SCHEMBL18575437 0.79 PKM (0.57) PKMKMT2AALDH1A1HTTMITF
SCHEMBL22766709 0.79 ALDH1A1 (0.48) KMT2AALDH1A1HTTMITFLMNA
SCHEMBL20909104 0.79 CYP3A4 (0.61) PKMKMT2AALDH1A1HTTMITF
Methane SCHEMBL29025301 0.77 CASR (0.59) PKMKMT2AALDH1A1HTTMITF
SCHEMBL918548 0.77 CA1 (0.50) PKMKMT2AALDH1A1HTTMITF
SCHEMBL12226363 0.77 CA1 (0.50) PKMKMT2AALDH1A1HTTMITF
SCHEMBL4589366 0.77 PKM (0.54) PKMKMT2AALDH1A1HTTMITF
SCHEMBL8751378 0.76 PKM (0.48) PKMKMT2AALDH1A1HTTMITF
SCHEMBL31080779 0.75 PKM (0.54) PKMKMT2AALDH1A1HTTMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3694836-B1 PROCESS FOR PREPARING INTERMEDIATE OF ANTI-TUMOR DRUG NIRAPARIB AND INTERMEDIATE THEREOF ZAI LAB SHANGHAI CO LTD (CN) 2022-06-15 EP disclosed
WO-2019072237-A1 PROCESS FOR PREPARING INTERMEDIATE OF ANTI-TUMOR DRUG NIRAPARIB AND INTERMEDIATE THEREOF ZAI LAB (SHANGHAI) CO., LTD. (CN) 2019-04-18 WO disclosed